Technical Analysis for FWBI - First Wave BioPharma, Inc.

Grade Last Price % Change Price Change
F 4.72 -8.53% -0.44
FWBI closed down 4.97 percent on Friday, February 3, 2023, on 43 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish -8.53%
MACD Bearish Centerline Cross Bearish -8.53%
50 DMA Support Bullish -8.53%
NR7 Range Contraction -8.53%
Narrow Range Bar Range Contraction -8.53%
Wide Bands Range Expansion -8.53%
20 DMA Resistance Bearish -13.07%
50 DMA Support Bullish -13.07%
MACD Bullish Centerline Cross Bullish -13.07%
Pocket Pivot Bullish Swing Setup -13.07%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 6 hours ago
10 DMA Resistance about 7 hours ago
Down 5% about 7 hours ago
Down 3% about 7 hours ago
Fell Below Previous Day's Low about 7 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

First Wave BioPharma, Inc. Description

First Wave BioPharma, Inc., a clinical stage biopharmaceutical company, focuses on the development of recombinant proteins for the treatment of gastrointestinal diseases. Its therapeutic products administer patients as oral non-systemic biologics. The company's lead therapeutic is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency. It is also developing two clinical programs using proprietary formulations of niclosamide, a pro-inflammatory pathway inhibitor, including FW-420, for grade 1 Immune Checkpoint Inhibitor-associated colitis and diarrhea in oncology patients; and FW-1022, for COVID-19 gastrointestinal infections. First Wave BioPharma, Inc. has a license agreement with First Wave Bio, Inc. The company was formerly known as AzurRx BioPharma, Inc. and changed its name to First Wave BioPharma, Inc. in September 2021. First Wave BioPharma, Inc. was incorporated in 2014 and is based in Boca Raton, Florida.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Health Sciences Pharmacy Therapeutic Products Diarrhea Checkpoint Inhibitor Gastrointestinal Disease Exocrine Pancreatic Insufficiency

Is FWBI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 348.6
52 Week Low 3.0352
Average Volume 618,081
200-Day Moving Average 32.05
50-Day Moving Average 5.12
20-Day Moving Average 5.34
10-Day Moving Average 5.25
Average True Range 1.03
RSI 53.70
ADX 42.11
+DI 38.18
-DI 7.17
Chandelier Exit (Long, 3 ATRs) 5.88
Chandelier Exit (Short, 3 ATRs) 6.93
Upper Bollinger Bands 6.84
Lower Bollinger Band 3.83
Percent B (%b) 0.44
BandWidth 56.46
MACD Line -0.01
MACD Signal Line -0.03
MACD Histogram 0.0226
Fundamentals Value
Market Cap 156.93 Million
Num Shares 30.4 Million
EPS -0.90
Price-to-Earnings (P/E) Ratio -5.71
Price-to-Sales 0.00
Price-to-Book 1.67
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.66
Resistance 3 (R3) 5.67 5.53 5.57
Resistance 2 (R2) 5.53 5.40 5.52 5.54
Resistance 1 (R1) 5.34 5.32 5.27 5.33 5.52
Pivot Point 5.20 5.20 5.16 5.19 5.20
Support 1 (S1) 5.01 5.07 4.94 5.00 4.80
Support 2 (S2) 4.87 4.99 4.86 4.78
Support 3 (S3) 4.68 4.87 4.75
Support 4 (S4) 4.67